Point72 Asset Management, L.P. - Q4 2019 holdings

$19 Billion is the total value of Point72 Asset Management, L.P.'s 917 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .

 Value Shares↓ Weighting
PTCT  PTC THERAPEUTICS INCcall$19,212,000
+42.0%
400,0000.0%0.10%
+21.7%
STKL  SUNOPTA INC$13,809,000
+38.9%
5,523,4770.0%0.07%
+19.7%
CME  CME GROUP INC$12,050,000
-5.0%
60,0320.0%0.06%
-19.2%
APVO  APTEVO THERAPEUTICS INC$1,604,000
+11.2%
2,450,0000.0%0.01%
-11.1%
IDYA  IDEAYA BIOSCIENCES INC$1,482,000
-16.7%
197,6150.0%0.01%
-27.3%
KALA  KALA PHARMACEUTICALS INC$1,144,000
-3.1%
310,0000.0%0.01%
-14.3%
EPHE  ISHARES TRmsci philips etf$343,000
+2.4%
10,0000.0%0.00%0.0%
GREK  GLOBAL X FDSmsci greece etf$304,000
+8.6%
30,0000.0%0.00%0.0%
WTI  W & T OFFSHORE INC$121,000
+27.4%
21,7870.0%0.00%0.0%
VALPQ  VALARIS PLC$174,000
+35.9%
26,5720.0%0.00%0.0%
MGRC  MCGRATH RENTCORP$69,000
+9.5%
9000.0%0.00%
MGEN  MIRAGEN THERAPEUTICS INC$48,000
-34.2%
99,6910.0%0.00%
BYND  BEYOND MEAT INC$8,000
-46.7%
1000.0%0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TR41Q2 20248.3%
CME GROUP INC41Q2 20240.3%
AMAZON COM INC39Q2 20243.2%
META PLATFORMS INC38Q1 20242.2%
XENON PHARMACEUTICALS INC38Q2 20240.4%
CSX CORP37Q2 20241.3%
BUNGE LIMITED37Q2 20231.5%
VULCAN MATLS CO37Q2 20240.9%
BERRY PLASTICS GROUP INC37Q1 20240.8%
GENERAL MTRS CO36Q2 20241.1%

View Point72 Asset Management, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
Point72 Asset Management, L.P. Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Sphere Entertainment Co.June 24, 20241,560,1705.5%
UroGen Pharma Ltd.June 24, 20242,569,8266.2%
Olema Pharmaceuticals, Inc.June 14, 20243,225,2505.7%
MARAVAI LIFESCIENCES HOLDINGS, INC.June 10, 20244,481,0503.4%
Rapid7, Inc.May 21, 20243,121,4155.0%
Corvus Pharmaceuticals, Inc.May 09, 202417,050,3849.9%
Avid Bioservices, Inc.April 26, 20243,226,0065.1%
SUTRO BIOPHARMA, INC.April 05, 20245,791,5057.7%
Fox CorpMarch 26, 202412,046,1185.0%
LENZ Therapeutics, Inc.March 25, 2024864,9423.4%

View Point72 Asset Management, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-09-16
SC 13G2024-09-05
N-PX2024-09-03
13F-HR/A2024-08-19
13F-HR2024-08-14
SC 13G2024-07-02
SC 13G2024-06-24
SC 13G2024-06-24
SC 13G2024-06-14
SC 13G2024-06-10

View Point72 Asset Management, L.P.'s complete filings history.

Compare quarters

Export Point72 Asset Management, L.P.'s holdings